← Back to Clinical Trials
Recruiting NCT06769477

NCT06769477 The Effect of Education Given to Type 2 Diabetics on Diabetes Self-management, Health Fatalism and Metabolic Parameters

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06769477
Status Recruiting
Phase
Sponsor Ataturk University
Condition Type 2 Diabetes
Study Type INTERVENTIONAL
Enrollment 66 participants
Start Date 2025-02-01
Primary Completion 2025-05-01

Trial Parameters

Condition Type 2 Diabetes
Sponsor Ataturk University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 66
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-02-01
Completion 2025-05-01
Interventions
Experimental Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to examine the effects on diabetes self-management, health fatalism and metabolic parameters of individuals with type 2 diabetes. The study will be conducted in a health institution between February 2025 and May 2025 and participants will be assigned to experimental and control groups by simple random sampling method. The experimental group will be trained with motivational interviewing techniques based on the health belief model for 8 weeks, followed by sending reminder SMS for 4 weeks. The control group will receive no intervention. The study is expected to improve the self-care behaviors of individuals with diabetes by creating positive effects on diabetes management and health fatalism.

Eligibility Criteria

Inclusion Criteria: * Having type 2 diabetes for at least 6 months * To be over 18 years old * Have sufficient communication skills to answer verbal and written questions and fulfill instructions * Becoming literate * No physical, cognitive or mental impairment in answering the questions * Willingness to participate in research. Exclusion Criteria: * Under 18 years of age * Being hospitalized in inpatient treatment institutions due to DM or DM complications during the research process * The emergence of any health problem that prevents the person from continuing the research * Do not leave the study voluntarily.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology